Gene · 5798
Papers3,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The performance of the MODY calculator in a non-Caucasian, mixed-race population diagnosed with diabetes mellitus before 35 years of age. | Diabetol Metab Syndr | 2023 | 36747290 | PubTator, text mining | PubMed |
| The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes. | Front Immunol | 2023 | 36733487 | PubTator, text mining | PubMed |
| SMPD4 regulates mitotic nuclear envelope dynamics and its loss causes microcephaly and diabetes. | Brain | 2023 | 36732302 | PubTator, text mining | PubMed |
| Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort. | Metabolism | 2023 | 36731720 | PubTator, text mining | PubMed |
| Ethnic differences in complement system biomarkers and their association with metabolic health in men of Black African and White European ethnicity. | Clin Exp Immunol | 2023 | 36722378 | PubTator, text mining | PubMed |
| Hyperglycaemic hyperosmolar state and cerebral thrombophlebitis in paediatrics: A case report. | Endocrinol Diabetes Metab | 2023 | 36722309 | PubTator, text mining | PubMed |
| Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study. | Ther Adv Endocrinol Metab | 2023 | 36699944 | PubTator, text mining | PubMed |
| Difference in the early clinical course between children with type 1 diabetes having a single antibody and those having multiple antibodies against pancreatic β-cells. | Endocr J | 2023 | 36696992 | PubTator, text mining | PubMed |
| Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors. | J Endocr Soc | 2023 | 36694808 | PubTator, text mining | PubMed |
| Cell differentiation modifies the p53 transcriptional program through a combination of gene silencing and constitutive transactivation. | Cell Death Differ | 2023 | 36681780 | PubTator, text mining | PubMed |
| Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices. | Micromachines (Basel) | 2023 | 36677212 | PubTator, text mining | PubMed |
| Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment. | Cancers (Basel) | 2023 | 36672324 | PubTator, text mining | PubMed |
| Monitoring of Autoantibodies Following Autologous Hematopoietic Stem Cell Transplantation in 6 Children with Recently Diagnosed Type 1 Diabetes Mellitus. | Med Sci Monit | 2023 | 36659834 | PubTator, text mining | PubMed |
| Update information on type 1 diabetes in children/adolescents and adults. | J Diabetes Investig | 2023 | 36659815 | PubTator, text mining | PubMed |
| Epitope-based precision immunotherapy of Type 1 diabetes. | Hum Vaccin Immunother | 2023 | 36656048 | PubTator, text mining | PubMed |
| Identification of biomarkers predictive of metastasis development in early-stage colorectal cancer using network-based regularization. | BMC Bioinformatics | 2023 | 36647008 | PubTator, text mining | PubMed |
| Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression. | Diabetologia | 2023 | 36633628 | PubTator, text mining | PubMed |
| New-onset type 1 diabetes and Graves' disease after antiretroviral therapy in a patient with human immunodeficiency virus infection. | J Diabetes Investig | 2023 | 36625362 | PubTator, text mining | PubMed |
| CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients. | Clin Exp Immunol | 2023 | 36622793 | PubTator, text mining | PubMed |
| Implementation of an evidence-based management algorithm for patients with chronic pancreatitis (COMBO trial): study protocol for a stepped-wedge cluster-randomized controlled trial. | Trials | 2023 | 36611202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5798/papers?page=17